Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06333899
Title Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Nationwide Children's Hospital
Age Groups: adult | child
Covered Countries USA | NLD | DEU | CAN | AUS

Additional content available in CKB BOOST